Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice

被引:106
作者
Oh, J
Takahashi, R
Adachi, E
Kondo, S
Kuratomi, S
Noma, A
Alexander, DB
Motoda, H
Okada, A
Seiki, M
Itoh, T
Itohara, S
Takahashi, C
Noda, M
机构
[1] Kyoto Univ, Sch Med, Dept Mol Oncol, Sakyo Ku, Kyoto 6068501, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan
[3] Kitasato Univ, Grad Sch Med Sci, Dept Physiol & Biophys, Kanagawa 2288555, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Phys & Biophys, Sakyo Ku, Kyoto 6068501, Japan
[5] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Tokyo 1088639, Japan
[6] Shionogi & Co Ltd, Discovery Res Labs, Fukushima Ku, Osaka 5530002, Japan
[7] RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan
关键词
MMP-2; MT1-MMP; angiogenesis; myogenesis;
D O I
10.1038/sj.onc.1207688
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The matrix metalloproteinase (MMP) family (similar to25 members in mammals) has been implicated in extracellular matrix remodeling associated with embryonic development, cancer formation and progression, and various other physiological and pathological events. Inactivating mutations in individual matrix metalloproteinase genes in mice described so far, however, are nonlethal at least up to the first few weeks after birth, suggesting functional redundancy among MMP family members. Here, we report that mice lacking two MMPs, MMP-2 (nonmembrane type) and MT1-MMP ( membrane type), die immediately after birth with respiratory failure, abnormal blood vessels, and immature muscle fibers reminiscent of central core disease. In the absence of MMP-2 and MT1-MMP, myoblast fusion in vitro is also significantly retarded. These findings suggest functional overlap in mice between the two MMPs with distinct molecular natures.
引用
收藏
页码:5041 / 5048
页数:8
相关论文
共 36 条
[1]   Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes [J].
Atkinson, SJ ;
Crabbe, T ;
Cowell, S ;
Ward, RV ;
Butler, MJ ;
Sato, H ;
Seiki, M ;
Reynolds, JJ ;
Murphy, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (51) :30479-30485
[2]   RAT MYOBLAST FUSION REQUIRES METALLOENDOPROTEASE ACTIVITY [J].
COUCH, CB ;
STRITTMATTER, WJ .
CELL, 1983, 32 (01) :257-265
[3]   Furin and membrane type-1 metalloproteinase mRNA levels and activation of metalloproteinase-2 are associated with arterial remodeling [J].
de Kleijn, DPV ;
Sluijter, JPG ;
Smit, J ;
Velema, E ;
Richard, W ;
Schoneveld, AH ;
Pasterkamp, G ;
Borst, C .
FEBS LETTERS, 2001, 501 (01) :37-41
[4]  
Deryugina EI, 2002, CANCER RES, V62, P580
[5]   Dystroglycan in development and disease [J].
Durbeej, M ;
Henry, MD ;
Campbell, KP .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (05) :594-601
[6]   New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[7]  
FAHIME EE, 2000, EXP CELL RES, V258, P279
[8]   MISSENSE MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE CAUSE CENTRAL CORE DISEASE IN HYPERTROPHIC CARDIOMYOPATHY [J].
FANANAPAZIR, L ;
DALAKAS, MC ;
CYRAN, F ;
COHN, G ;
EPSTEIN, ND .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) :3993-3997
[9]   Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model [J].
Fang, JM ;
Shing, Y ;
Wiederschain, D ;
Yan, L ;
Butterfield, C ;
Jackson, G ;
Harper, J ;
Tamvakopoulos, G ;
Moses, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) :3884-3889
[10]  
FELIPE MI, 1983, HISTOCHEM PATHOL, P319